Moderna, Inc. Director Noubar B. Afeyan is set to sell 15,000 shares of the company's common stock, with an aggregate market value of approximately $2.06 million, on 06/26/2024. The shares were originally acquired on 05/01/2012 through a private placement from the issuer. This planned transaction follows a series of sales over the past three months, where a total of 402,832 shares were sold for gross proceeds of over $55 million. The notice of the upcoming sale was filed on the same date as the planned sale, with the sale instructions having been adopted on 11/07/2023.

Moderna, Inc. Director Noubar B. Afeyan is set to sell 15,000 shares of the company's common stock, with an aggregate market value of approximately $2.06 million, on 06/26/2024. The shares were originally acquired on 05/01/2012 through a private placement from the issuer. This planned transaction follows a series of sales over the past three months, where a total of 402,832 shares were sold for gross proceeds of over $55 million. The notice of the upcoming sale was filed on the same date as the planned sale, with the sale instructions having been adopted on 11/07/2023.